Comparison of Ceftibuten Vs. Amoxicillin/clavulanic Acid As Antibiotic Prophylaxis in Cholecystectomy And/or Biliary Tract Surgery

Overview

Journal J Gastrointest Surg

Specialty Gastroenterology

Date 2001 Apr 18

PMID 11307095

Citations 3

Authors

H Orozco

J Sifuentes-Osornio

C Chan

H Medina-Franco

F Vargas-Vorackova

E Prado

J Arch

Affiliations

Soon will be listed here.

Abstract

A randomized, comparative, prospective clinical trial was carried out at a tertiary care center to compare the efficacy of two antibiotic regimens in the prophylaxis of postoperative infection in patients undergoing biliary tract surgery. One hundred patients undergoing cholecystectomy or biliary tract exploration were randomly allocated to one of the following antibiotic regimens: the standard regimen of three doses of amoxicillin/clavulanic acid (1000/200 mg) given by intravenous infusion, or a single dose of ceftibuten (400 mg) given orally. Patients were monitored during their stay in the hospital and over a 2 week period as outpatients. Fifty adult patients were included in each group. Mean age was 49 years, and sex distribution was 82 women and 18 men. The groups were comparable in terms of demographic characteristics and comorbidity. There were no cases of postoperative infection in the ceftibuten group, but five cases of infection occurred in the amoxicillin/clavulanic acid group (P < 0.05). No adverse effects were observed with either antibiotic. The treatment cost per patient was significantly lower for ceftibuten. The results indicate that ceftibuten is well tolerated and more effective than amoxicillin/clavulanic acid for prophylaxis following gallbladder and biliary tract surgery. In addition, ceftibuten has the advantage of being more cost-effective and easier to administer than amoxicillin/clavulanic acid so it could be considered as an alternative for antibiotic prophylaxis in these types of surgical procedures.

Citing Articles

Clinical Presentation and Incidence of Anaerobic Bacteria in Surgically Treated Biliary Tract Infections and Cholecystitis.

Strohaker J, Wiegand L, Beltzer C, Konigsrainer A, Ladurner R, Meier A Antibiotics (Basel). 2021; 10(1).

PMID: 33450979 PMC: 7828425. DOI: 10.3390/antibiotics10010071.

Role of prophylactic antibiotics in laparoscopic cholecystectomy: a meta-analysis.

Choudhary A, Bechtold M, Puli S, Othman M, Roy P J Gastrointest Surg. 2008; 12(11):1847-53.

PMID: 18780131 DOI: 10.1007/s11605-008-0681-x.

Antibiotic prophylaxis in elective laparoscopic cholecystectomy. Lack of need or lack of evidence?.

Catarci M, Mancini S, Gentileschi P, Camplone C, Sileri P, Grassi G Surg Endosc. 2004; 18(4):638-41.

PMID: 14752639 DOI: 10.1007/s00464-003-9090-0.

References

Rosenfeld R, Doyle W, Swarts J, Seroky J, Greene I . Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study. Ann Otol Rhinol Laryngol. 1993; 102(3 Pt 1):222-6. DOI: 10.1177/000348949310200310. View

McArdle C, Morran C, ANDERSON J, Pettit L, Gemmell C, SLEIGH J . Oral ciprofloxacin as prophylaxis in gastroduodenal surgery. J Hosp Infect. 1995; 30(3):211-6. DOI: 10.1016/s0195-6701(95)90316-x. View

Bauernfeind A, Jungwirth R . Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil. Infection. 1991; 19(5):353-62. DOI: 10.1007/BF01645369. View

Nungu K, Olerud C, Rehnberg L, Larsson S, Nordell P, Allvin I . Prophylaxis with oral cefadroxil versus intravenous cefuroxime in trochanteric fracture surgery. A clinical multicentre study. Arch Orthop Trauma Surg. 1995; 114(6):303-7. DOI: 10.1007/BF00448952. View

Soussy C, Meyran M, Chanal M, Reverdy M, Kitzis M, DERLOT E . [In vitro antibacterial activity of a new oral cephalosporin, ceftibuten. Results of a multicenter study]. Pathol Biol (Paris). 1991; 39(5):396-402. View

Barr W, Lin C, Radwanski E, Lim J, SYMCHOWICZ S, Affrime M . The pharmacokinetics of ceftibuten in humans. Diagn Microbiol Infect Dis. 1991; 14(1):93-100. DOI: 10.1016/0732-8893(91)90096-x. View

Fassbender M, Lode H, Schaberg T, Borner K, Koeppe P . Pharmacokinetics of new oral cephalosporins, including a new carbacephem. Clin Infect Dis. 1993; 16(5):646-53. DOI: 10.1093/clind/16.5.646. View

Kearns G, Young R . Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use. Clin Pharmacokinet. 1994; 26(3):169-89. DOI: 10.2165/00003088-199426030-00002. View

Orozco H, Sifuentes Osornio J, Prado E, Takahashi T, Lopez Graniel C, Anaya E . [Comparison of two antimicrobial prophylaxis regimens in biliary tract surgery: a randomized controlled clinical trial]. Rev Invest Clin. 1993; 45(6):565-9. View

10.

Debbia E, Pesce A, Chiesa M, Ricotta N, Schito G . Microbiologic profile of ceftibuten, a new oral cephalosporin. Drugs Exp Clin Res. 1992; 18(4):129-39. View

11.

Burdon D . Principles of antimicrobial prophylaxis. World J Surg. 1982; 6(3):262-7. DOI: 10.1007/BF01653540. View

12.

Botto H, Levy S, Delval C . [Oral ofloxacin versus intramuscular ceftriaxone in antibiotic prophylaxis in transurethral prostate resection]. Prog Urol. 1993; 3(4):569-75. View

13.

Lode H, Fassbender M, Schaberg T, Borner K, Koeppe P . Comparative pharmacokinetics of the new oral cephalosporins. Drugs. 1994; 47 Suppl 3:10-9; discussion 19-20. DOI: 10.2165/00003495-199400473-00004. View

14.

Gorbach S, Condon R, Conte Jr J, Kaiser A, Ledger W, Nichols R . Evaluation of new anti-infective drugs for surgical prophylaxis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992; 15 Suppl 1:S313-38. DOI: 10.1093/clind/15.supplement_1.s313. View

15.

McArdle C, Morran C, Pettit L, Gemmell C, SLEIGH J, Tillotson G . Value of oral antibiotic prophylaxis in colorectal surgery. Br J Surg. 1995; 82(8):1046-8. DOI: 10.1002/bjs.1800820814. View

16.

Chin N, Gu J, Neu H . Antimicrobial effects of the combination of ceftibuten and an orally absorbed penem SCH 29482. Diagn Microbiol Infect Dis. 1991; 14(1):79-83. DOI: 10.1016/0732-8893(91)90093-u. View

17.

Prado D, Lopez E, Liu H, Devoto S, Woloj M, Contrini M . Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease. Pediatr Infect Dis J. 1992; 11(8):644-7. View

18.

Risberg B, Drott C, Dalman P, Holm J, Ivarsson L, Jivegard L . Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postoperative infection in vascular surgery: a randomised double-blind, prospective multicentre study. Eur J Vasc Endovasc Surg. 1995; 10(3):346-51. DOI: 10.1016/s1078-5884(05)80055-3. View

19.

Wise R . The pharmacokinetics of the oral cephalosporins--a review. J Antimicrob Chemother. 1990; 26 Suppl E:13-20. DOI: 10.1093/jac/26.suppl_e.13. View

20.

Keighley M, Baddeley R, Burdon D, Edwards J, Quoraishi A . A controlled trial of parenteral prophylactic gentamicin therapy in biliary surgery. Br J Surg. 1975; 62(4):275-9. DOI: 10.1002/bjs.1800620406. View